Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 15, 2018

SELL
$44.22 - $75.47 $14.4 Million - $24.5 Million
-325,000 Closed
0 $0
Q2 2018

Aug 01, 2018

BUY
$72.38 - $92.5 $369,138 - $471,750
5,100 Added 1.59%
325,000 $26 Million
Q1 2018

Apr 20, 2018

BUY
$69.46 - $88.57 $6.49 Million - $8.28 Million
93,500 Added 41.3%
319,900 $27.7 Million
Q4 2017

Jan 22, 2018

BUY
$65.94 - $93.31 $14.9 Million - $21.1 Million
226,400
226,400 $15.6 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.